Automation accelerates the drug discovery and development process by using AI to identify potential drug candidates more quickly and accurately. Automated systems can screen thousands of compounds and predict their efficacy against specific cancer types, significantly reducing the time and cost associated with traditional drug development methods. This innovation has the potential to bring new cancer therapies to market faster than ever before.
